Join us for a 1-hour webinar on the FDA's Project Patient Voice initiative to find out what this means for the future of drug development

Our perspectives on the patient-reported data from oncology studies via the FDA's Project Patient Voice.

On July 17, the FDA is holding a virtual workshop to provide a forum for open discussion between academia, industry, international regulatory, and patient advocacy groups to advance measurement of the patient experience as it relates to oncology treatment tolerability data. This is part of the FDA's pilot Project Patient Voice (PPV) initiative which is based on the development of a web-based public source of patient experience data that is accessible to patients, caregivers, and providers in support of the 21st Century Cures Act. 

This webinar will outline how PPV is taking a significant step in recognizing both tolerability and patient experience data as key elements of oncology evidence generations plans, and making this data available directly to patients.